Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION - PI …
{{id}} {{{paragraph}}}
Example: marketing
HIGHLIGHTS OF PRESCRIBING INFORMATION - PI …
HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use symbicort safely and effectively. See full PRESCRIBING INFORMATION for (budesonide and formoterol fumarate dihydrate)Inhalation Aerosol, for oral inhalation useInitial Approval: 2006------------------------------------ ---- RECENT MAJOR CHANGES ---------------------------------------B ox Warning, removed 12/2017 Indications and Usage ( ) 12/2017 Indications and Usage ( ) 9/2017 Warnings and Precautions ( ) 12/2017--------------------------------- ------- INDICATIONS AND USAGE ---------------------------------------- symbicort is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for: Treatment of asthma in patients 6 years of age and older. ( ) Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema.
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use SYMBICORT safely and effectively. See full prescribing information for SYMBICORT.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: